BIA/VWR Day - Defining the Biotech Lab of the Future

  • 21 Mar 18
  • King's Hedges Room, The Cambridge Building, Babraham, Cambridge
  • Print page

VWR International and the BIA invite you to our Networking and Workshop Event in Cambridge on 21 March 2018. We hope that you will join us for this excellent opportunity to share experiences, and observe some best practice from the experts - as well as connecting with a wide range of industry specialists. Free to attend.  

Discussion panels on the day will include:

  • The Cambridge Infrastructure Challenge
  • Brexit and the Modern Industrial Strategy
  • Evolution of manufacturing of Advanced Therapies
  • Talent challenges at the interface of biology and technology

Speakers will include:

  • Tarquin Bennett-Coles, Global Talent Scout, Innovative Medicines and Early Development (iMED), AstraZeneca
  • Maria Ferguson, Director of Human Resources, Cambridge Epigenetix
  • Richard Hammond, Technology Director, Cambridge Consultants
  • Dr Sabine Jaccaud, Director, Cambridge Communications, AstraZeneca
  • Eric Johnsson, Policy and Public Affairs Executive, BIA
  • Derek Jones, Chief Executive, Babraham Research Campus
  • Dr Jim Mills, Senior Vice President - Technical Operations, Abzena
  • Rob Sadler, Director, Savills
  • Dr Martin Turner, Policy and Projects Manager, BIA

Download the delegate invite for more information

This free of charge event will include:

  • Overview of industry trends
  • An day of workshops with BIA and other organisations
  • Networking lunch
  • Dinner hosted by VWR. Guest speaker will be Steve Bates, Chief Executive Officer, BIA
  • Discounted local accommodation
  • Breakfast with BIA the following day. You must register seperately for this event.
  • Plenty of networking opportunities and exchange of insight and ideas throughout both days
Event venue

King's Hedges Room
The Cambridge Building
Babraham Research Campus
CB22 3AT
 United Kingdom

Dinner venue

Tamburlaine Hotel
27-29 Station Rd

Private dining in Cambridge, 15 minute drive from Babraham

Tarquin Bennett-Coles

Global Talent Scout, Innovative Medicines and Early Development (iMED)


Maria Ferguson

Director of Human Resources

Cambridge Epigenetix

Maria is a senior executive with extensive experience of working within FTSE 100 and NASDAQ publicly quoted companies and within private equity portfolio businesses. Maria has an MBA and has developed a portfolio career that spans a number of market-sectors including banking, media, logistics and retail. Maria brings to CEGX a wealth of knowledge and pragmatism of delivering strategies and people plans for growth and diversification.

Richard Hammond

Technology Director and Head of Synthetic Biology

Cambridge Consultants

Richard is Technology Director and Head of Synthetic Biology at Cambridge Consultants. Richard has twenty years' experience in design and development of products and processes for the healthcare and life-sciences industries. His particular interest is how new ideas and techniques in manipulating and modifying biological systems are translated into widely-available products and therapies. Prior to joining Cambridge Consultants, Richard worked for Alere Inc. where he was responsible for development of the Alere i infectious disease diagnostic platform. Richard holds BA, MA and MEng degrees from the University of Cambridge.

Dr Sabine Jaccaud

Director, Cambridge Communications


Eric Johnsson

Policy and Public Affairs Executive


Eric joined the BIA in March 2017. Previously he worked for the NHS in patient confidentiality and data protection. As a student, in Australia and Scotland, he held part-time positions in legal and parliamentary research.

Originally from Sweden, Eric holds a 1st Class Masters degree in International Economic Law from the University of Edinburgh and a Bachelor of Arts in Politics and International Relations from Murdoch University in Australia.

In his spare time, Eric enjoys the martial art of Brazilian Jiu-Jitsu and travelling to warm and sunny locations.

Derek Jones

Chief Executive

Babraham Research Campus

Jim Mills

Senior Vice President Technical Operations


Jim joined Abzena’s executive team in March 2015 as VP Technical Operations. He was previously CEO of Cantab Biopharmaceuticals having originally joined the company in 1997 as part of the Process Development group. Jim has a background in bioprocess development and GMP manufacturing, which includes having run Xenova Biomanufacturing as a Contract Manufacturing Organisation. Jim has a PhD in microbial physiology and biochemistry and a first degree in Biotechnology.

Rob Sadler



Savills is a truly multidisciplinary real estate advisor employing in excess of 30,000 real estate experts in over 700 offices and Associates throughout the globe. This depth and breadth of expertise means that you can be assured of a highly responsive, quality service, where you need it. Our strength is our people and we are committing to attracting developing and motivating the best in the business. The calibre of our personnel is something of which we are most proud and we have assembled a team which will deliver the things that matter most to you.

Savills is currently taking forward some of the UK’s newest and largest life science developments. Our integrated in-house team includes strategists, market analysts, specialist designers, master planners and technical specialists together with the UK’s leading investment, brand and marketing specialists. In addition, we undertake market analysis and monitor national and international best practice trends.

Rob is Head of Office for Cambridge and Head of Commercial for the Eastern Region with over 18 years’ experience in the commercial property field, including all aspects of commercial development, agency, professional valuations and corporate consultancy. Rob specialises in Business Space development and Life Science. Rob joined Savills in 2005 and became a Director in March 2009.

Dr Martin Turner

Policy and Projects Manager


Martin joined the BIA in April 2016 as Policy and Projects Manager. He is responsible for innovation policy and industrial strategy. He also provides the secretariat for the BIA’s Finance and Tax Advisory Committee and the Intellectual Property Advisory Committee.

Martin has 5 years’ experience in policy and public affairs and has worked at the Royal Society, the Campaign for Science and Engineering, and the Association of Medical Research Charities. Before embarking on a career in policy, Martin completed a PhD in molecular biology at the University of Sheffield, where he also co-founded and was director of an award-winning science communication charity called Science Brainwaves. He has a BSc in molecular biology from the University of Manchester.



BIA Annual Supporters